These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27762202)

  • 41. Patient acceptable symptomatic state (PASS).
    Pham T; Tubach F
    Joint Bone Spine; 2009 Jul; 76(4):321-3. PubMed ID: 19525136
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of pain in rheumatic diseases.
    Sokka T
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S77-84. PubMed ID: 16273789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why the HAQ-II can be an effective substitute for the HAQ.
    Wolfe F
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S29-30. PubMed ID: 16273782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complex measures and indices for clinical research compared with simple patient questionnaires to assess function, pain, and global estimates as rheumatology "vital signs" for usual clinical care.
    Pincus T; Bergman MJ; Maclean R; Yazici Y
    Rheum Dis Clin North Am; 2009 Nov; 35(4):779-86, ix. PubMed ID: 19962622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treat-to-target in rheumatology].
    Majdan M
    Wiad Lek; 2015; 68(3):259-64. PubMed ID: 26753210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interventional ultrasound: a critical overview on ultrasound-guided injections and biopsies.
    Epis O; Bruschi E
    Clin Exp Rheumatol; 2014; 32(1 Suppl 80):S78-84. PubMed ID: 24529311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Continuous quick development of rheumatology].
    Madsen OR; Terslev L; Tarp U; Jacobsen S; Ostergaard M
    Ugeskr Laeger; 2009 Mar; 171(13):1092. PubMed ID: 19321087
    [No Abstract]   [Full Text] [Related]  

  • 48. Validation of the French version of the Compliance Questionnaire for Rheumatology (CQR-5), a self-reporting questionnaire specific to patients with chronic inflammatory rheumatic disease.
    Cavagna P; Hubert J; Bottois C; Lopez-Medina C; Roux C; Conort O; Dougados M
    Joint Bone Spine; 2022 Nov; 89(6):105449. PubMed ID: 35944599
    [No Abstract]   [Full Text] [Related]  

  • 49. [Institute of Rheumatology and progress of antirheumatic therapy].
    Sigidin IaA
    Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in Pediatric Rheumatology: July 2015-June 2016.
    Sharma A; Vignesh P; Jindal AK; Gupta A
    Int J Rheum Dis; 2017 Apr; 20(4):504-509. PubMed ID: 28205425
    [No Abstract]   [Full Text] [Related]  

  • 51. Do we have blind spots in our diagnostic vision?
    Nived O; Sturfelt G
    J Rheumatol; 2005 Jan; 32(1):3-5. PubMed ID: 15630717
    [No Abstract]   [Full Text] [Related]  

  • 52. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T
    Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. It's good to feel better but it's better to feel good.
    Dougados M
    J Rheumatol; 2005 Jan; 32(1):1-2. PubMed ID: 15630716
    [No Abstract]   [Full Text] [Related]  

  • 54. Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies.
    Utley M; Gallivan S; Young A; Cox N; Davies P; Dixey J; Emery P; Gough A; James D; Prouse P; Williams P; Winfield J; Devlin JA
    Rheumatology (Oxford); 2000 Jan; 39(1):1-2. PubMed ID: 10662865
    [No Abstract]   [Full Text] [Related]  

  • 55. Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care.
    Pincus T; Sokka T
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S1-9. PubMed ID: 16273778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Choosing Wisely: the American College of Rheumatology's Top 5 for pediatric rheumatology.
    Rouster-Stevens KA; Ardoin SP; Cooper AM; Becker ML; Dragone LL; Huttenlocher A; Jones KB; Kolba KS; Moorthy LN; Nigrovic PA; Stinson JN; Ferguson PJ;
    Arthritis Care Res (Hoboken); 2014 May; 66(5):649-57. PubMed ID: 24756998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative measures to assess patients with rheumatic diseases: 2006 update.
    Pincus T; Sokka T
    Rheum Dis Clin North Am; 2006 Dec; 32 Suppl 1():29-36. PubMed ID: 17410699
    [No Abstract]   [Full Text] [Related]  

  • 58. DANBIO: a nationwide registry of biological therapies in Denmark.
    Hetland ML
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S205-7. PubMed ID: 16273809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement.
    van der Linden S; Boonen A; van Tubergen A; Vosse D; Dekker J; Dijkmans B; van der Horst-Bruinsma I; Kapinga T; van der Leeden M; van den Ende C; Hazes JM; Linssen A; Vliet Vlieland T
    Clin Exp Rheumatol; 2016; 34(1 Suppl 95):S15-7. PubMed ID: 26316176
    [No Abstract]   [Full Text] [Related]  

  • 60. Sociological aspects of rheumatic patients.
    Armstrong D
    Baillieres Clin Rheumatol; 1987 Dec; 1(3):455-66. PubMed ID: 3331330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.